## Review setup
- **Input scope** Abstract only
- **Assessment boundary** Claims and evidence as presented in the abstract; no access to full text, figures, tables, or supplementary materials
- **Shared manuscript claim summary** The authors report crystal or solution structures of the LMX1a homeobox domain bound to promoter DNA sequences from WNT1 and Pitx3, describe a bipartite recognition mechanism involving the alpha3 helix in the major groove and an N-terminal loop in the minor groove, validate binding contributions through structure-based mutations, characterize an NSHL-associated mutation (R199) via experimental and MD simulation approaches, and demonstrate functional effects of Lmx1a overexpression on neuronal differentiation and target gene transcription in SH-SY5Y cells.
- **Visible evidence base** Abstract text only; no structural coordinates, statistics, figures, or experimental details are available
- **Missing materials affecting confidence** Full manuscript, all figures and tables, structural statistics, binding affinity data, MD simulation parameters and trajectories, cell-based assay details, and any statistical analyses

## Reviewer
- **Overall assessment** The abstract presents a potentially interesting structural study of a homeobox domain recognizing an A/T-rich motif, with implications for mDA neuron development and a disease-associated mutation. The proposed bipartite recognition mechanism is plausible and consistent with known homeodomain-DNA interactions. However, the abstract alone does not provide sufficient quantitative evidence to evaluate the robustness of the structural conclusions, the functional relevance of the mutations, or the strength of the cellular differentiation data. The work may be of interest to structural biologists and developmental neuroscientists, but the current evidence base is too limited to establish the case.
- **Who would be interested in the results, and why** Structural biologists studying protein-DNA recognition, particularly homeodomain proteins, would be interested in the detailed binding mechanism. Developmental neuroscientists studying midbrain dopaminergic neuron specification would value the functional link to WNT1 and PITX3 regulation. Clinically oriented researchers may note the NSHL-associated mutation and its structural consequence. The interdisciplinary appeal is moderate, primarily spanning structural biology and neurodevelopment.
- **Major strengths** The study addresses a specific and biologically relevant question, namely how LMX1a recognizes its target promoters. The combination of structural determination, mutagenesis, MD simulations, and cellular assays provides a multi-pronged approach. The identification of a disease-associated mutation and its structural effect adds translational relevance.
- **Major Concerns** 
  - R1-M1
  - R1-M2
  - R1-M3
- **Minor Comments** 
  - R1-m1
  - R1-m2
  - R1-m3
- **Technical failings that need to be addressed before the case is established** The abstract does not report any quantitative binding data, structural resolution statistics, or statistical significance for the cellular assays. Without these, the central claims of specific recognition and functional consequence cannot be rigorously evaluated.
- **Assessment against Nature-style criteria** Originality: moderate, as homeodomain-DNA recognition is well studied, though the specific LMX1a target motif and the NSHL mutation provide some novelty. Scientific importance: moderate, given the role of LMX1a in mDA neuron development, but the advance over existing homeodomain paradigms is not clearly articulated. Interdisciplinary readership: limited, as the work primarily targets structural biology and neurodevelopment specialists. Technical soundness: not assessable from the abstract alone, as no structural or binding statistics are provided. Readability for nonspecialists: the abstract is generally clear but uses domain-specific terminology without sufficient context for a broad audience.
- **Recommendation posture** Currently not established from the provided evidence. The abstract suggests a potentially sound study, but the lack of quantitative data and methodological detail prevents a supportive recommendation.

### Major Concerns

- **Concern ID** R1-M1
- **Severity** Major
- **Blocking** Yes
- **Axis** Evidence sufficiency
- **Claim pointer** The abstract claims that the complex structures revealed specific target recognition via the alpha3 helix and N-terminal loop, and that structure-based mutations significantly reduced binding affinity.
- **Evidence pointer** Abstract text; no figures or tables provided
- **Concern** The abstract states that structures were determined and that mutations reduced binding affinity, but no quantitative data are presented. There is no mention of resolution, R-factors, binding constants, or statistical significance. The phrase "significantly reduced" is unsupported without numerical values or error estimates.
- **Why it matters** The central structural and biochemical claims rest on these data. Without quantitative evidence, the reader cannot assess whether the observed effects are robust or within experimental noise. This is a core requirement for a structural biology paper.
- **Resolution test** Provide binding affinity values (e.g., Kd) for wild-type and mutant proteins with appropriate replicates and statistical tests, and report structural quality metrics such as resolution and refinement statistics.

- **Concern ID** R1-M2
- **Severity** Major
- **Blocking** Yes
- **Axis** Claim consistency
- **Claim pointer** The abstract claims that the R199 mutation yields a more flexible loop and disturbs minor groove recognition, consistent with MD simulations.
- **Evidence pointer** Abstract text; MD simulation details not provided
- **Concern** The abstract asserts consistency between experimental observations and MD simulations, but no simulation methodology, convergence criteria, or quantitative comparison metrics are described. The phrase "consistent with" is vague and does not establish a rigorous link between the two approaches.
- **Why it matters** The R199 mutation is presented as a key finding with potential clinical relevance. If the MD and experimental data are not quantitatively compared, the claim of consistency is anecdotal rather than demonstrated. This weakens the mechanistic interpretation.
- **Resolution test** Describe MD simulation parameters, simulation length, and provide quantitative measures of loop flexibility (e.g., RMSF) for wild-type and mutant, with a clear statistical comparison to experimental observations.

- **Concern ID** R1-M3
- **Severity** Major
- **Blocking** Yes
- **Axis** Functional relevance
- **Claim pointer** The abstract claims that overexpression of Lmx1a promoted differentiation of SH-SY5Y cells and upregulated WNT1 and PITX3 transcription.
- **Evidence pointer** Abstract text; no experimental details or statistics provided
- **Concern** The cellular differentiation and transcriptional upregulation claims are presented without any quantitative data, such as differentiation markers, fold-change in gene expression, or statistical tests. The abstract does not specify the time course, controls, or whether the effects are direct or indirect.
- **Why it matters** These functional data are intended to bridge the structural findings to biological relevance. Without quantitative support, the claim that the structural insights have functional implications is not established. This is essential for the paper's broader significance.
- **Resolution test** Provide quantitative differentiation assays (e.g., percentage of cells with neuronal morphology or marker expression) and qPCR or RNA-seq data with statistical analysis for WNT1 and PITX3 expression, including appropriate controls.

### Minor Comments

- **Concern ID** R1-m1
- **Severity** Minor
- **Axis** Clarity
- **Affected element** Abstract wording
- **Evidence pointer** Abstract text
- **Issue** The phrase "employed its alpha3 helix and an N-terminal loop to achieve specific target recognition" is somewhat vague. It is unclear whether the loop is the N-terminal arm of the homeodomain or a distinct loop, and how "specific" is defined relative to other homeodomains.
- **Required correction** Clarify the structural terminology and define specificity, for example by comparing binding to non-specific or mutated DNA sequences.

- **Concern ID** R1-m2
- **Severity** Minor
- **Axis** Completeness
- **Affected element** Mutation rationale
- **Evidence pointer** Abstract text
- **Issue** The abstract mentions "structure-based mutations" but does not specify which residues were mutated beyond R199, nor the rationale for their selection.
- **Required correction** List the specific mutations and briefly state the structural rationale for each, or refer to a figure that provides this information.

- **Concern ID** R1-m3
- **Severity** Minor
- **Axis** Context
- **Affected element** Comparison to prior work
- **Evidence pointer** Abstract text
- **Issue** The abstract does not place the findings in the context of previously characterized homeodomain-DNA interactions, which would help assess novelty.
- **Required correction** Add a sentence comparing the LMX1a recognition mode to known homeodomain paradigms, such as the classic engrailed or MATalpha2 structures.

## Risk / unsupported claims
- The claim that the alpha3 helix and N-terminal loop achieve "specific target recognition" is unsupported without binding data to non-specific DNA or competition assays.
- The claim that R199 yields a "more flexible loop" is unsupported without quantitative flexibility measurements or MD analysis details.
- The claim that Lmx1a overexpression "promoted differentiation" is unsupported without quantitative differentiation metrics.
- The claim that the work "provides a detailed elucidation" is overstated given the lack of quantitative evidence in the abstract.
- The structural coordinates and refinement quality are not assessable from the abstract.